Found: 8
Select item for more details and to access through your institution.
Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis.
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1026168
- By:
- Publication type:
- Article
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01063-5
- By:
- Publication type:
- Article
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01063-5
- By:
- Publication type:
- Article
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01063-5
- By:
- Publication type:
- Article
Syndecan-1 modulates the invasive potential of endometrioma via TGF-β signalling in a subgroup of women with endometriosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mifepristone mediates anti-proliferative effect on ovarian mesenchymal stem/stromal cells from female BRCA<sup>1-/2-</sup> carriers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article